Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$2.58 - $3.68 $51,713 - $73,761
-20,044 Reduced 32.64%
41,374 $113,000
Q2 2022

Aug 15, 2022

SELL
$2.95 - $5.85 $48,214 - $95,612
-16,344 Reduced 21.02%
61,418 $181,000
Q1 2022

May 12, 2022

SELL
$3.3 - $5.69 $115,500 - $199,150
-35,000 Reduced 31.04%
77,762 $407,000
Q4 2021

Feb 11, 2022

BUY
$4.02 - $18.0 $453,303 - $2.03 Million
112,762 New
112,762 $489,000

Others Institutions Holding BRTX

About BioRestorative Therapies, Inc.


  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.62M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track This Portfolio

Track Ayrton Capital LLC Portfolio

Follow Ayrton Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrton Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrton Capital LLC with notifications on news.